Poppers, Nitrous, and Beyond

Patterns of Inhalant Use Across Sexual Identity Groups in the U.S., 2021-2023

Megan S. Schuler, Michael S. Dunbar, Rajeev Ramchand

ResearchPosted on rand.org Apr 9, 2026Published in: International Journal of Drug Policy, Volume 151, 105235 (May 2026). DOI: 10.1016/j.drugpo.2026.105235

Purpose

Inhalant use, including “poppers” (e.g., alkyl nitrites), remains disproportionately common among sexual minority adults, yet national data on recent use patterns and behavioral health correlates are limited.

Methods

We analyzed nationally representative 2021–2023 National Survey on Drug Use and Health data, estimating prevalence of lifetime, past-year, and past-month inhalant use by sexual identity, sex, and age. Among sexual minority adults, we examined age-specific patterns and identified correlates of past-year use among gay males, bisexual males, and bisexual females (lesbian/gay female users excluded due to small sample size).

Results

Lifetime inhalant use was highest among gay males (39.4%) and bisexual males (28.9%), compared to 10.8% of heterosexual males and 5.8% of heterosexual females. Past-year inhalant use was reported by 10.8% of gay males, 5.1% of bisexual males, and 2.1% of bisexual females (<1% among heterosexual adults). Among sexual minority adults, age patterns of use diverged: prevalence was highest among middle-aged gay and bisexual males but was concentrated among younger bisexual females. Among past-year users, bisexual females were disproportionately young, socioeconomically disadvantaged, and had higher polysubstance use relative to gay and bisexual males. Multivariable models confirmed subgroup-specific correlates: cocaine and methamphetamine use and higher income among gay males; prescription stimulants and higher income among bisexual males; and polysubstance use and younger ages among bisexual females.

Conclusions

While inhalant use remains concentrated among sexual minority males, bisexual females represent an understudied group with elevated use and distinct risk profiles, including polysubstance use.

Topics

Document Details

  • Publisher: Elsevier B.V
  • Availability: Non-RAND
  • Year: 2026
  • Pages: 8
  • Document Number: EP-71290

Research conducted by

This publication is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.